GE Finalizes Acquisition of Certain Thermo Fisher Assets | GenomeWeb

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has completed the sale of certain assets to GE, the companies said today.

Specifically, GE acquired Thermo Fisher's HyClone cell culture media and sera, as well as its gene modulation and magnetic beads businesses, for $1.065 billion.

The businesses will become part of GE Healthcare's Life Sciences division, and will allow the company to expand its offering of tool, technologies, and services for the discovery and manufacture of new medicines, vaccines, and diagnostics, GE said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.